Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Evidence based treatment of heart failure
Autore:
Escasany, AA; Dalmau, MD; de Bolos, JMA; Cumplido, DR; Fadini, ED; Rodriguez, JC; Basilio, EG; Lorite, NM;
Indirizzi:
Hosp Vall Hebron, Serv Farmacol Clin, Fundac Inst Catala Farm, Barcelona 08035, Spain Hosp Vall Hebron Barcelona Spain 08035 tala Farm, Barcelona 08035, Spain Hosp Vall Hebron, Serv Cardiol, Fundac Inst Catala Farm, Barcelona 08035, Spain Hosp Vall Hebron Barcelona Spain 08035 tala Farm, Barcelona 08035, Spain ABS Raval Sud, Barcelona, Spain ABS Raval Sud Barcelona SpainABS Raval Sud, Barcelona, Spain Ciutat Sanitaria & Univ Bellvitge, Serv Cardiol, Lhospitalet De Llobregat,Barcelona, Spain Ciutat Sanitaria & Univ Bellvitge Lhospitalet De Llobregat Barcelona Spain
Titolo Testata:
REVISTA ESPANOLA DE CARDIOLOGIA
fascicolo: 6, volume: 54, anno: 2001,
pagine: 715 - 734
SICI:
0300-8932(200106)54:6<715:EBTOHF>2.0.ZU;2-Z
Fonte:
ISI
Lingua:
SPA
Soggetto:
IDIOPATHIC DILATED CARDIOMYOPATHY; LEFT-VENTRICULAR DYSFUNCTION; PLACEBO-CONTROLLED TRIAL; CONVERTING-ENZYME-INHIBITOR; CORONARY-ARTERY DISEASE; ACUTE MYOCARDIAL-INFARCTION; BETA-ADRENERGIC-BLOCKADE; COST-EFFECTIVENESS ANALYSIS; CONGESTIVE CARDIAC-FAILURE; LOW-DOSE AMIODARONE;
Keywords:
heart failure; conversive enzyme inhibitors; diuretics; beta blockers;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
185
Recensione:
Indirizzi per estratti:
Indirizzo: Escasany, AA Hosp Vall Hebron, Serv Farmacol Clin, Fundac Inst Catala Farm, P Vall Hebron,119-129, Barcelona 08035, Spain Hosp Vall Hebron P Vall Hebron,119-129 Barcelona Spain 08035
Citazione:
A.A. Escasany et al., "Evidence based treatment of heart failure", REV ESP CAR, 54(6), 2001, pp. 715-734

Abstract

Introduction and objectives. Recommendations for the treatment of heart failure were carried out by a systematic review of the available evidence of the different pharmacologic treatments. Material and methods. The review focused on the treatment of chronic and systolic heart failure. All the studies published in english about the pharmacologic treatment of heart failure where identified. The evidence of everypharmacologic treatment was classified according to: a) efficacy variables(reduction of mortality and hospitalizations, improvement of functional class, ejection fraction and exercice tolerance), and b) the level of qualityof the evidence according to an evaluation scale. The evidence was also reviewed for the comparisons and the combinations of the pharmacologic treatments, as well as for the toxicity and costs of treatments. Results. The recommendations were defined according to the NYHA functionalclass and were classified in the A, B and C cathegories according to the level of quality of the available evidence. The evidence on mortality was considered the most important. First line drugs, the alternatives and other possible treatments were take into account. Conclusions. There is enough evidence based on information about some variables such as reduction of mortality or hospitalizations to carry out treatment recommendations in all stages of heart failure. This point out the interest ant the priority of used them in the evaluation and improvement of the results of heart failure.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/07/20 alle ore 22:28:06